Results 131 to 140 of about 9,825 (155)

Application of different chemometric assisted models for spectrophotometric quantitative analysis of velpatasvir and sofosbuvir

Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2021
Ahmed Hussien, Mohamed Shahin
exaly  

Sofosbuvir + simeprevir dominates sofosbuvir + ribavirin

PharmacoEconomics & Outcomes News, 2014
openaire   +1 more source

Infrequent Development of Resistance in Genotype 1–6 Hepatitis C Virus–Infected Subjects Treated With Sofosbuvir in Phase 2 and 3 Clinical Trials

Clinical Infectious Diseases, 2014
Neil Parkin, Eric Lawitz, Edward Gane
exaly  

Ledipasvir/sofosbuvir/peginterferon/ribavirin/sofosbuvir

Reactions Weekly, 2016
openaire   +1 more source

Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs

Journal of Hepatology, 2019
Rafael Esteban, Zoe Marino, José A Carrión   +2 more
exaly  

Incidence of Hepatocellular Carcinoma after Treatment with Sofosbuvir-Based or Sofosbuvir-Free Regimens in Patients with Chronic Hepatitis C

Cancers, 2020
Norihiro Furusyo, Eiichi Ogawa, Masaki Kato   +2 more
exaly  

Sofosbuvir

Reactions Weekly, 2023
openaire   +1 more source

Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System

Gastroenterology, 2016
Lauren Beste, Feng Su, Judith Tsui
exaly  

The Combination of Simeprevir and Sofosbuvir Is More Effective Than That of Peginterferon, Ribavirin, and Sofosbuvir for Patients With Hepatitis C–Related Child's Class A Cirrhosis

Gastroenterology, 2015

exaly  

Structural basis for the severe adverse interaction of sofosbuvir and amiodarone on L-type Cav channels

Cell, 2022
exaly